If you are a man, you are more likely to develop a disease that will kill you. But if you are a woman, you are more likely to have health problems. Women they spend 25 percent more of their lives in needy health compared to men. This is the gender difference in health in a nutshell.
When a woman comes to hospital, she is less likely to have her pain assessed than a man, and if she is treated for pain, she will wait longer on average than a man for any treatment. If you suffer from a disease that only affects women, you may find that there are no satisfactory treatments. When she is given medications, they may not work as well as expected or cause side effects because they were likely tested primarily on men. Even if he suffers from a disease that affects both sexes, tests suggests that a man will be diagnosed later in life.
These are not the consequences of a single problem, but the result of many failures in society in general and in the health sector in particular. Sexism in healthcare systems where women’s symptoms are often ignored and misdiagnosed. Poorly designed clinical trials involving mainly men. biased research funding that is rarely spent on conditions that only affect women or on discovering how specific diseases affect women. And medical schools that don’t do enough to teach about women’s health.
AND latest report of the McKinsey Health Institute describes the gender health gap as “a $1 trillion opportunity to improve lives and economies” – such is the scale of the imbalance in women’s health care around the world. According to BMJclosing this gap in the UK could provide a £39 billion ($51 billion) boost to the UK economy. This would save lives and improve the well-being of millions of people – both women and men.
Almost two years since the first edition was published in the UK Women’s health strategyA 10-year plan to improve women’s health around the world, the UK Department of Health announced on Monday plans to offer “patient passports”, digital health data registries that can be accessed by various healthcare providers. We hope this move will speed up patient care and minimize errors. In lightweight of this, WIRED brought together experts from various health fields to provide their perspective on changes that could quickly and inexpensively impact women’s health.
Provide early screening programs for PCOS
Karen Joash, a leading specialist in obstetrics and gynecology
Polycystic ovary syndrome, or PCOS, is an endocrine disorder that affects approximately 10 percent of women of reproductive age worldwide. Although PCOS is a common disease, a significant problem is the delayed diagnosis of PCOS, which causes numerous long-term health consequences. Addressing this delay should be a priority for the government given the significant impact it has on public health.
Lack of health education is a critical factor contributing to delayed diagnosis: women are often unaware of symptoms such as irregular menstrual cycles, excess hair on parts of the body where there is usually little hair, and acne. If left untreated, PCOS can lead to solemn long-term effects, including cardiovascular disease, infertility and impaired glucose metabolism, significantly reducing quality of life and increasing health care costs.